Cited by 21Wound Healing and TreatmentsElectrospun Nanofibers in Biomedical ApplicationsTissue Engineering and Regenerative Medicine

PLCL/PCL Dressings with Platelet Lysate and Growth Factors Embedded in Fibrin for Chronic Wound Regeneration

Open access
Táborská, Johanka, Blanquer, Andreu, Brynda, Eduard, Filová, Elena, Stiborová, Lenka, Jenčová, Věra, Havlíčková, Kristýna, Riedelová, Zuzana +1 more·2023·International Journal of Nanomedicine

Abstract

Introduction: The formation of diabetic ulcers (DU) is a common complication for diabetic patients resulting in serious chronic wounds. There is therefore, an urgent need for complex treatment of this problem. This study examines a bioactive wound dressing of a biodegradable electrospun nanofibrous blend of poly(L-lactide-co-ε-caprolactone) and poly(ε-caprolactone) (PLCL/PCL) covered by a thin fibrin layer for sustained delivery of bioactive molecules. Methods: Electrospun PLCL/PCL nanofibers were coated with fibrin-based coating prepared by a controlled technique and enriched with human platelet lysate (hPL), fibroblast growth factor 2 (FGF), and vascular endothelial growth factor (VEGF). The coating was characterized by scanning electron microscopy and fluorescent microscopy. Protein content and its release rate and the effect on human saphenous vein endothelial cells (HSVEC) were evaluated. Results: The highest protein amount is achieved by the coating of PLCL/PCL with a fibrin mesh containing 20% v/v hPL (NF20). The fibrin coating serves as an excellent scaffold to accumulate bioactive molecules from hPL such as PDGF-BB, fibronectin (Fn), and α-2 antiplasmin. The NF20 coating shows both fast and a sustained release of the attached bioactive molecules (Fn, VEGF, FGF). The dressing significantly increases the viability of human saphenous vein endothelial cells (HSVECs) cultivated on a collagen-based wound model. The exogenous addition of FGF and VEGF during the coating procedure further increases the HSVECs viability. In addition, the presence of α-2 antiplasmin significantly stabilizes the fibrin mesh and prevents its cleavage by plasmin. Discussion: The NF20 coating supplemented with FGF and VEGF provides a promising wound dressing for the complex treatment of DU. The incorporation of various bioactive molecules from hPL and growth factors has great potential to support the healing processes by providing appropriate stimuli in the chronic wound.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ijn.s393890

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PLCL surface modification or covalent binding of bioactive molecules such as cell adhesion factors and cell growth factors can further improve compatibility with specific cells.

    “PLCL surface modification or covalent binding of bioactive molecules, such as cell adhesion factors and cell growth factors, can further improve their compatibility with specific cells [25–27].”

    From Application of PLCL as a biodegradable polymer in biomedical engineering (2026) · cites this paper as [26]

    The Introduction and Conclusion (pages not provided) describe PLCL/PCL nanofibers modified with a fibrin coating containing bioactive molecules. The Cell Viability results report improved growth of human endothelial cells with platelet lysate and added growth factors. The paper does not establish covalent binding of those molecules to PLCL/PCL, so that alternative in the claim is unsupported. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Táborská, J., Blanquer, A., Brynda, E., Filová, E., Stiborová, L., Jenčová, V., Havlíčková, K., Riedelová, Z., & Riedel, T.
Affiliations
  • Czech Academy of Sciences (CZ)
  • Universitat Autònoma de Barcelona (ES)
  • Technical University of Liberec (CZ)
Corresponding author
Riedel, Tomáš
Venue
International Journal of Nanomedicine
Published
2023-02
Volume
Volume 18
Pages
595-610
ISSN
  • 1176-9114 (ISSN-L)
  • 1178-2013
OpenAlex
W4319791703
Cited by
21
References
52
Citations by year
2026: 4 · 2025: 8 · 2024: 6 · 2023: 3
FWCI
2.30
Type
journal article
Language
en
Open access
Locations
  • International Journal of Nanomedicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • European Commission (LX22NPO5104)
  • Ministerstvo Zdravotnictví Ceské Republiky (LX22NPO5104)
  • Agentura Pro Zdravotnický Výzkum České Republiky (LX22NPO5104, NV18-01-00332)
  • NextGenerationEU
Topics
  • Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
  • Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
fibrin coating, platelet lysate, growth factor delivery, diabetic ulcers, chronic wound healing, electrospun nanofibers, fibroblast growth factor 2, vascular endothelial growth factor, alpha2-antiplasmin, endothelial cell viability, sustained protein release, wound dressings
MeSH terms
alpha-2-Antiplasmin, Bandages, Humans, Polyesters, Wound Healing, Vascular Endothelial Growth Factor A, Endothelial Cells, Nanofibers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review